Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine / K. N. R. Chengappa en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 311-316 Título : Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine Tipo de documento: texto impreso Autores: K. N. R. Chengappa, Autor ; Bruce G. Pollock, Autor ; Haranath Parepally, Autor Fecha de publicación: 2023 Artículo en la página: pp. 311-316 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Atropina, Enfermedades del sistema nervioso autónomo, Antagonistas colinérgicos, Clozapina, Antagonistas muscarínicos, Pirenzepina, Trastornos psicóticos. Resumen: This study evaluated anticholinergic effects among patients with schizophrenia, schizoaffective disorder, or bipolar I disorder who were receiving either olanzapine (N = 12) or clozapine (N = 12) at standard clinical doses in a naturalistic setting. Serum anticholinergic levels were determined in adult male and female subjects using a radioreceptor binding assay. The Udvalg for Kliniske Undersogelser Scale was used to evaluate anticholinergic side effects clinically, and the Mini-Mental State Examination provided a global cognitive measure. Link: ./index.php?lvl=notice_display&id=31197 [artículo] Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine [texto impreso] / K. N. R. Chengappa, Autor ; Bruce G. Pollock, Autor ; Haranath Parepally, Autor . - 2023 . - pp. 311-316. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 311-316 Palabras clave: Antipsicóticos, Atropina, Enfermedades del sistema nervioso autónomo, Antagonistas colinérgicos, Clozapina, Antagonistas muscarínicos, Pirenzepina, Trastornos psicóticos. Resumen: This study evaluated anticholinergic effects among patients with schizophrenia, schizoaffective disorder, or bipolar I disorder who were receiving either olanzapine (N = 12) or clozapine (N = 12) at standard clinical doses in a naturalistic setting. Serum anticholinergic levels were determined in adult male and female subjects using a radioreceptor binding assay. The Udvalg for Kliniske Undersogelser Scale was used to evaluate anticholinergic side effects clinically, and the Mini-Mental State Examination provided a global cognitive measure. Link: ./index.php?lvl=notice_display&id=31197

---

1 (1 - 1 / 1)